missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Beskrivelse
- FK-866 is a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme that regulates NAD+ biosynthesis from the natural precursor nicotinamide (Cameron et al.; Hasmann & Schemainda)
- In hepatocarcinoma cells, FK-866 activates AMP-activated protein kinase (AMPK) and downregulates mammalian target of rapamycin (mTOR) signaling (Schuster et al.)
- FK-866 can be used to deplete NAD+, a central metabolism cofactor (Cameron et al.; Hasmann & Schemainda; Jadeja et al.)
- Depletes NAD+ and induces delayed cell death by apoptosis in HepG2 human liver carcinoma cells (IC50 = ∼1 nM; Hasmann & Schemainda)
- Triggers dose-dependent cytotoxicity in multiple myeloma cells (Cea et al.)
- Induces autophagic death in neuroblastoma SH-SY5Y cells (IC50 = 0.93 nM; Billington et al.)
Tekniske data
Tekniske data
CAS | 658084-64-1 |
Synonym | K 22.175 |
Mængde | 5 mg |
Molekylær formel | C24H29N3O2 |
Renhed | ≥98% |
Korrektion af produktindhold
Fisher Scientific Encompass-programmet tilbyder varer, som ikke er en del af vores distributionsportefølje. Disse produkter har typisk ikke billeder eller detaljerede beskrivelser. Vi er dog forpligtet til at forbedre din shoppingoplevelse. Brug formularen nedenfor til at give feedback relateret til indholdet på dette produkt.
Produkttitel
STEMCELL Technologies FK-866
Ser du en mulighed for forbedring?Del en indholdskorrektion